Parity as a Prognostic Factor in Patients with Advanced-Stage Epithelial Ovarian Cancer

Parity as a Prognostic Factor in Patients with Advanced-Stage Epithelial Ovarian Cancer

Abolfazl Khalafi-Nezhad,1 Vahid Ebrahimi,2 Fatemeh Ahmadpour,3 Mozhdeh Momtahan,3 Minoo Robati,3 Zahra Saraf,3 Mani Ramzi,1 Zahra Jowkar,4 Parvin Ghaffari5 1Hematology Research Center, Department of Hematology, Medical Oncology and Stem Cell Transplantation, Shiraz University of Medical Sciences, Sh...

Full description

Bibliographic Details
Main Authors: Khalafi-Nezhad A, Ebrahimi V, Ahmadpour F, Momtahan M, Robati M, Saraf Z, Ramzi M, Jowkar Z, Ghaffari P
Format: Article
Language:English
Published: Dove Medical Press 2020-02-01
Series:Cancer Management and Research
Subjects:
advanced-stage epithelial ovarian cancer
early-stage epithelial ovarian cancer
parity
overall survival
stratified cox-adjusted regression.
Online Access:https://www.dovepress.com/parity-as-a-prognostic-factor-in-patients-with-advanced-stage-epitheli-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/parity-as-a-prognostic-factor-in-patients-with-advanced-stage-epitheli-peer-reviewed-article-CMAR

Similar Items